George Kemble

SGMT

George Kemble serves as Executive Chairman at Sagimet Biosciences Inc. (SGMT). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$408.4K

Net Position

Net Seller

$408.4K

Companies Traded

SGMT

Active Period

Jul 2024 – Nov 2025

3 total trades

Most Recent

Sell SGMT

Nov 21, 2025 · $290.0K

George Kemble's Insider Trading at Sagimet Biosciences Inc. (SGMT)

Buys

0 · $0.00

Sells

3 · $408.4K

Total Shares Bought

Total Shares Sold

75,375

SGMT Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Nov 21, 2025	Sell	37,688	$7.69	$290.0K	81,005
Jul 25, 2024	Sell	23,625	$3.17	$74.8K	118,693
Jul 23, 2024	Sell	14,062	$3.10	$43.6K	142,318

Related Insiders

Thierry Chauche

officer: Chief Financial Officer

SGMTSell · Feb 12, 2026

David Happel

President & CEO

SGMTSell · Feb 12, 2026

Eduardo Bruno Martins

officer: Chief Medical Officer

SGMTSell · Feb 12, 2026

Elizabeth Rozek

officer: Chief Legal & Admin. Officer

SGMTSell · Feb 12, 2026

Explore More Insider Trading Data

SGMT Insider Trading Activity

View all insider trades at Sagimet Biosciences Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity